Beijing SL Pharmaceutical Co Ltd

002038.SZ

$1.15

Closing

▼-1.43%

1D

▼-18.55%

YTD

Market cap

$1.18B

52 week high

$2.22

52 week low

$0.97

Volume

12,885,420

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$1.18B

Analysts' Rating

-

Price Target (Mean)

0.00

Total Analysts

0

P/E

27.15

Operating Margin

-2.98%

Beta

0.69

Revenue Growth (Annual)

-

52 week high

$2.22

52 week low

$0.97

Div. Yield

1.20%

EPS Annual Growth

0.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Beijing SL Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of genetic engineering and related drugs. The Company’s main products include complex coenzyme, arsenic trioxide, recombinant human granulocyte stimulating factor, recombinant human interleukin-2, recombinant human basic fibroblast growth factor, thymopentin, enoxaparin and Xingling dropping pills, among others. The Company distributes its products in domestic market and to overseas markets.